06:22 AM EST, 11/08/2024 (MT Newswires) -- Dynavax Technologies ( DVAX ) said late Thursday that it has authorized the repurchase of up to $200 million in stock.

The repurchase program lacks an expiration date. The pharmaceutical company said it expects that purchases to be completed within a year.

Price: 11.61, Change: -0.17, Percent Change: -1.44